,dataset_name,cell_type,cell_type_ontology_id,donor_id,sex,race,development_stage,count,percentage
0,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",T cell,CL:0000084,SG_HEL_H380,female,Indian,30-year-old human stage,5,0.28752156411730884
1,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",B cell,CL:0000236,SG_HEL_H380,female,Indian,30-year-old human stage,7,0.4025301897642324
2,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",monocyte,CL:0000576,SG_HEL_H380,female,Indian,30-year-old human stage,9,0.5175388154111558
3,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",natural killer cell,CL:0000623,SG_HEL_H380,female,Indian,30-year-old human stage,1,0.05750431282346176
4,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta T cell",CL:0000624,SG_HEL_H380,female,Indian,30-year-old human stage,200,11.500862564692351
5,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta T cell",CL:0000625,SG_HEL_H380,female,Indian,30-year-old human stage,40,2.3001725129384707
6,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mature B cell,CL:0000785,SG_HEL_H380,female,Indian,30-year-old human stage,1,0.05750431282346176
7,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",plasma cell,CL:0000786,SG_HEL_H380,female,Indian,30-year-old human stage,5,0.28752156411730884
8,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",memory B cell,CL:0000787,SG_HEL_H380,female,Indian,30-year-old human stage,40,2.3001725129384707
9,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",naive B cell,CL:0000788,SG_HEL_H380,female,Indian,30-year-old human stage,67,3.8527889591719378
10,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta cytotoxic T cell",CL:0000794,SG_HEL_H380,female,Indian,30-year-old human stage,76,4.370327774583094
11,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",gamma-delta T cell,CL:0000798,SG_HEL_H380,female,Indian,30-year-old human stage,16,0.9200690051753881
12,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",regulatory T cell,CL:0000815,SG_HEL_H380,female,Indian,30-year-old human stage,28,1.6101207590569295
13,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD4-positive, alpha-beta T cell",CL:0000895,SG_HEL_H380,female,Indian,30-year-old human stage,121,6.958021851638872
14,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD8-positive, alpha-beta T cell",CL:0000900,SG_HEL_H380,female,Indian,30-year-old human stage,181,10.408280621046579
15,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","central memory CD4-positive, alpha-beta T cell",CL:0000904,SG_HEL_H380,female,Indian,30-year-old human stage,97,5.57791834387579
16,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","effector memory CD4-positive, alpha-beta T cell",CL:0000905,SG_HEL_H380,female,Indian,30-year-old human stage,33,1.897642323174238
17,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta memory T cell",CL:0000909,SG_HEL_H380,female,Indian,30-year-old human stage,57,3.27774583093732
18,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta cytotoxic T cell",CL:0000934,SG_HEL_H380,female,Indian,30-year-old human stage,16,0.9200690051753881
19,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-negative, CD56-bright natural killer cell, human",CL:0000938,SG_HEL_H380,female,Indian,30-year-old human stage,7,0.4025301897642324
20,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-positive, CD56-dim natural killer cell, human",CL:0000939,SG_HEL_H380,female,Indian,30-year-old human stage,227,13.05347901092582
21,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mucosal invariant T cell,CL:0000940,SG_HEL_H380,female,Indian,30-year-old human stage,47,2.7027027027027026
22,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD14-positive monocyte,CL:0001054,SG_HEL_H380,female,Indian,30-year-old human stage,328,18.861414606095458
23,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",innate lymphoid cell,CL:0001065,SG_HEL_H380,female,Indian,30-year-old human stage,1,0.05750431282346176
24,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD14-low, CD16-positive monocyte",CL:0002396,SG_HEL_H380,female,Indian,30-year-old human stage,109,6.267970097757332
25,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD1c-positive myeloid dendritic cell,CL:0002399,SG_HEL_H380,female,Indian,30-year-old human stage,19,1.0925819436457735
26,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",double negative T regulatory cell,CL:0011024,SG_HEL_H380,female,Indian,30-year-old human stage,1,0.05750431282346176
